Startup Waiv Spins Out of Owkin With $33M to Bring AI Precision to Cancer Decisions – MedCity News
Cancer treatment is evolving with a growing number of therapies designed to address specific targets expressed by tumors or genetic…
Cancer treatment is evolving with a growing number of therapies designed to address specific targets expressed by tumors or genetic…
Waiv, a Paris-based medical testing startup spun out of biotech unicorn Owkin, has raised a $33m funding round co-led by…
• 5 minutes ago • 3 Mins Read The initiative seeks to transform fragmented cancer data into AI-ready insights aimed…